Ford launches new AI to grow multibillion-dollar Pro commercial business
2023 Ford Super Duty F-550 Chassis Cab Ford DETROIT — Ford Motor is launching a new artificial intelligence system for
Read More
Business
FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism
The Food and Drug Administration on Tuesday approved a decades-old prescription vitamin called leucovorin as the first treatment for a
Read More
Spirit Airlines to recall furloughed pilots to combat attrition as carrier eyes bankruptcy
A Spirit Airlines Airbus A320 taxis at Los Angeles International Airport after arriving from Boston on September 1, 2024 in
Read More
Olaplex stock has plunged since its IPO. Here’s how the hair care brand is trying to turn
When prestige hair care brand Olaplex first debuted on the Nasdaq in late 2021, it surpassed pricing predictions and gained
Read More
Lego keeps beating the toy industry. Its secret weapon is not what you’d expect
Lego just put up another banner year — with help from a behind-the-scenes secret weapon. The Danish company on Tuesday
Read More
Stellantis taps Toyota, Bosch suppliers for hybrid technologies for new Jeeps
2026 Jeep Cherokee. Courtesy: Stellantis DETROIT — Jeep maker Stellantis is leaning on technologies from automotive suppliers for its newest
Read More
Ticketmaster parent Live Nation reaches settlement with Department of Justice over antitrust
Signs are seen at the Live Nation NYC headquarters on May 23, 2024 in New York City. Michael M. Santiago
Read More
Inside the booming business of wellness third spaces and membership clubs
A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t
Read More
FDA vaccine head will step down in April after string of controversial decisions
The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human
Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from
Read More